Summary:
Click image to enlargeThe purpose of this study is to evaluate the efficacy and safety of Saroglitazar Magnesium 4 mg Tablet once a daily in women with well-characterized PCOS diagnosed with NAFLD.
Qualified Participants Must:
Females 18-45 years of age
Previously confirmed diagnosis of PCOS
Qualified Participants May Receive:
Compensation for taking part in this research study.